Chromocell Therapeutics C... (CHRO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.68
-0.02 (-0.74%)
At close: Jan 23, 2025, 3:59 PM
2.86
6.70%
After-hours Jan 23, 2025, 07:38 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -7.38M | -2.46M | -595.39K | -660.58K |
Depreciation & Amortization | 188.12K | n/a | n/a | n/a |
Stock-Based Compensation | 3.96M | 110.15K | n/a | n/a |
Other Working Capital | 424.07K | 227.26K | 71.87K | n/a |
Other Non-Cash Items | 201.60K | -163.03K | 585.91K | 2.97M |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.05M | 640.86K | -755.83K | -2.97M |
Operating Cash Flow | -981.03K | -1.57M | -1.59M | -3.63M |
Capital Expenditures | 1.00 | n/a | n/a | n/a |
Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a |
Debt Repayment | 766.94K | 400.00K | n/a | 241.79K |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 1.22M | 1.59M | 3.38M |
Financial Cash Flow | 1.02M | 1.62M | 1.59M | 3.63M |
Net Cash Flow | 41.32K | 55.07K | n/a | n/a |
Free Cash Flow | -981.03K | -1.57M | -1.59M | -3.63M |